National Science Foundation Restricts New Grants to Four Universities
The U.S. National Science Foundation has limited new research grants to four elite universities. The change began last month and affects institutions including Princeton University.
winnipegfreepress.comThe U.S. National Science Foundation has restricted the flow of new research grants to a group of elite universities, Nature has learnt. Princeton University in New Jersey is one of four institutions to which the foundation began restricting research grants last month. Its science library is shown in publicly available photographs.
The foundation is described as a major funder of basic research. The restriction applies to new awards and does not affect existing grants. No named officials are identified in the report. The action follows an earlier decision to fire the foundation's entire science advisory board.
Key Facts
Story Timeline
2 events- Last month
National Science Foundation began restricting new grants to four universities.
1 source@Nature - Prior to last month
Trump administration fired the foundation's entire science advisory board.
1 source@Nature
Potential Impact
- 01
Affected universities may receive fewer new federal research awards.
- 02
Researchers at the four institutions could seek funding from other agencies.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…